NELLIE BOONE: Open Payments
NPI 1134317803 · CHEWELAH, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$248 in 13 payments from 7 companies in 2025. Trend: 2023 $405 · 2024 $396 · 2025 $248
Food & beverage: $248
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 5 | $66 |
| Novo Nordisk Inc | 2 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Dexcom, Inc. | 1 | $27 |
| Corcept Therapeutics | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: VOQUEZNA, JARDIANCE, Ozempic, FARXIGA, Dexcom G6 Transmitter, Korlym, REXULTI.
Industry payments across WA — which companies pay providers there.
